US HB4733 | 2017-2018 | 115th Congress
Status
Sponsorship: Moderate Partisan Bill (Democrat 23-6)
Status: Introduced on December 21 2017 - 25% progression, died in committee
Action: 2018-01-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 21 2017 - 25% progression, died in committee
Action: 2018-01-03 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Opioids and STOP Pain Initiative Act This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including: understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016; improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and supporting the Federal Pain Research Strategy. NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.
Title
Opioids and STOP Pain Initiative Act
Sponsors
| Sen. Peter Welch [D-VT] | Rep. David McKinley [R-WV] | Sen. Ruben Gallego [D-AZ] | Rep. Ro Khanna [D-CA] |
| Rep. David Cicilline [D-RI] | Rep. Peter King [R-NY] | Rep. Eliot Engel [D-NY] | Rep. John Larson [D-CT] |
| Rep. Earl Blumenauer [D-OR] | Rep. Anna Eshoo [D-CA] | Rep. Jamie Raskin [D-MD] | Rep. Donald Payne [D-NJ] |
| Rep. Zoe Lofgren [D-CA] | Rep. Ann Kuster [D-NH] | Rep. John Duncan [R-TN] | Rep. Debbie Dingell [D-MI] |
| Rep. Alexander Mooney [R-WV] | Rep. John Culberson [R-TX] | Rep. Seth Moulton [D-MA] | Rep. Julia Brownley [D-CA] |
| Rep. Elizabeth Esty [D-CT] | Rep. Suzanne Bonamici [D-OR] | Rep. James McGovern [D-MA] | Rep. Conor Lamb [D-PA] |
| Rep. Evan Jenkins [R-WV] | Rep. Beto O'Rourke [D-TX] | Rep. Steve Cohen [D-TN] | Rep. Jared Huffman [D-CA] |
| Rep. James Langevin [D-RI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-01-03 | House | Referred to the Subcommittee on Health. |
| 2017-12-22 | House | Referred to the Subcommittee on Health. |
| 2017-12-21 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-12-21 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-12-21 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2017-12-21 | House | Introduced in House |
Same As/Similar To
SB2260 (Related) 2017-12-21 - Read twice and referred to the Committee on Finance.
HB5531 (Related) 2018-05-22 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
HB5531 (Related) 2018-05-22 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Subjects
Charitable contributions
Congressional oversight
Department of Health and Human Services
Drug therapy
Drug trafficking and controlled substances
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Income tax credits
Medical research
National Institutes of Health (NIH)
Prescription drugs
Research administration and funding
Research and development
Social work, volunteer service, charitable organizations
User charges and fees
Congressional oversight
Department of Health and Human Services
Drug therapy
Drug trafficking and controlled substances
Health
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Health technology, devices, supplies
Income tax credits
Medical research
National Institutes of Health (NIH)
Prescription drugs
Research administration and funding
Research and development
Social work, volunteer service, charitable organizations
User charges and fees
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/4733/all-info |
| Text | https://www.congress.gov/115/bills/hr4733/BILLS-115hr4733ih.pdf |
